Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICP-332 in Moderate to Severe Plaque Psoriasis
NCT07251998Phase 2Recruiting
- Sponsor
- InnoCare Pharma
- Start
- Dec 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of soficitinib in plaque psoriasis, sponsored by InnoCare Pharma. Started Dec 2025; status: recruiting.
02
Drugs
soficitinib
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07251998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07251998.